Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, Melanie Schirmer, Julian Avila-Pacheco, Tiffany W Poon, Elizabeth Andrews, Nadim J Ajami, Kevin S Bonham, Colin J Brislawn, David Casero, Holly Courtney, Antonio Gonzalez, Thomas G Graeber, A Brantley Hall, Kathleen Lake, Carol J Landers, Himel Mallick, Damian R Plichta, Mahadev Prasad, Gholamali Rahnavard, Jenny Sauk, Dmitry Shungin, Yoshiki Vázquez-Baeza, Richard A White 3rd, IBDMDB Investigators, Jonathan Braun, Lee A Denson, Janet K Jansson, Rob Knight, Subra Kugathasan, Dermot P B McGovern, Joseph F Petrosino, Thaddeus S Stappenbeck, Harland S Winter, Clary B Clish, Eric A Franzosa, Hera Vlamakis, Ramnik J Xavier, Curtis Huttenhower, Jason Bishai, Kevin Bullock, Amy Deik, Courtney Dennis, Jess L Kaplan, Hamed Khalili, Lauren J McIver, Christopher J Moran, Long Nguyen, Kerry A Pierce, Randall Schwager, Alexandra Sirota-Madi, Betsy W Stevens, William Tan, Johanna J Ten Hoeve, George Weingart, Robin G Wilson, Vijay Yajnik, Jason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, Melanie Schirmer, Julian Avila-Pacheco, Tiffany W Poon, Elizabeth Andrews, Nadim J Ajami, Kevin S Bonham, Colin J Brislawn, David Casero, Holly Courtney, Antonio Gonzalez, Thomas G Graeber, A Brantley Hall, Kathleen Lake, Carol J Landers, Himel Mallick, Damian R Plichta, Mahadev Prasad, Gholamali Rahnavard, Jenny Sauk, Dmitry Shungin, Yoshiki Vázquez-Baeza, Richard A White 3rd, IBDMDB Investigators, Jonathan Braun, Lee A Denson, Janet K Jansson, Rob Knight, Subra Kugathasan, Dermot P B McGovern, Joseph F Petrosino, Thaddeus S Stappenbeck, Harland S Winter, Clary B Clish, Eric A Franzosa, Hera Vlamakis, Ramnik J Xavier, Curtis Huttenhower, Jason Bishai, Kevin Bullock, Amy Deik, Courtney Dennis, Jess L Kaplan, Hamed Khalili, Lauren J McIver, Christopher J Moran, Long Nguyen, Kerry A Pierce, Randall Schwager, Alexandra Sirota-Madi, Betsy W Stevens, William Tan, Johanna J Ten Hoeve, George Weingart, Robin G Wilson, Vijay Yajnik
Abstract
Inflammatory bowel diseases, which include Crohn's disease and ulcerative colitis, affect several million individuals worldwide. Crohn's disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study's infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi'omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Conflict of interest statement
J. Braun is on the Scientific Advisory Board for Janssen Research & Development, LLC. C.H. is on the Scientific Advisory Board for Seres Therapeutics. J.F.P. and N.J.A. own shares at Diversigen Inc. R.J.X. is a consultant to Novartis and Nestle.
Figures
References
- Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 2015;12:720–727.
- Hugot JP, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.
- Huang H, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;547:173–178.
- Morgan XC, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.
- Gevers D, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382–392.
- Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489–1499. doi: 10.1053/j.gastro.2014.02.009.
- Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig. Dis. Sci. 2015;60:290–298.
- Knights D, et al. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med. 2014;6:107.
- Halfvarson J, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat. Microbiol. 2017;2:17004.
- Lloyd-Price J, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 2017;550:61–66.
- Vandeputte D, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65:57–62.
- Weisshof R, Chermesh I. Micronutrient deficiencies in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care. 2015;18:576–581.
- Kuroki F, et al. Multiple vitamin status in Crohn’s disease. Correlation with disease activity. Dig. Dis. Sci. 1993;38:1614–1618.
- Depeint F, Bruce WR, Shangari N, Mehta R, O’Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem. Biol. Interact. 2006;163:94–112.
- Li J, et al. Niacin ameliorates ulcerative colitis via prostaglandin D2-mediated D prostanoid receptor 1 activation. EMBO Mol. Med. 2017;9:571–588.
- Figge HL, et al. Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man. J. Clin. Pharmacol. 1988;28:1136–1140.
- Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29–32.
- Frank DN, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA. 2007;104:13780–13785.
- Hall AB, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017;9:103.
- Kruis W, Kalek HD, Stellaard F, Paumgartner G. Altered fecal bile acid pattern in patients with inflammatory bowel disease. Digestion. 1986;35:189–198.
- Duboc H, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62:531–539.
- Meadows JA, Wargo MJ. Carnitine in bacterial physiology and metabolism. Microbiology. 2015;161:1161–1174.
- Scher JU, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife. 2013;2:e01202.
- Abu-Ali GS, et al. Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nat. Microbiol. 2018;3:356–366.
- Morgan XC, et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol. 2015;16:67.
- Linge HM, et al. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob. Agents Chemother. 2008;52:2599–2607.
- Eckhardt ER, et al. Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterol. 2010;10:133.
- El Hassani RA, et al. Dual oxidase2 is expressed all along the digestive tract. Am. J. Physiol. Gastrointest. Liver Physiol. 2005;288:G933–G942.
- Bachman MA, Miller VL, Weiser JN. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog. 2009;5:e1000622.
- Kanehisa M, et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014;42:D199–D205.
- Haberman Y, et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J. Clin. Invest. 2014;124:3617–3633.
- Kugathasan S, et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet. 2017;389:1710–1718.
- Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. Novel mechanisms and functions of complement. Nat. Immunol. 2017;18:1288–1298.
- Ross IN, Thompson RA, Montgomery RD, Asquith P. Significance of serum complement levels in patients with gastrointestinal disease. J. Clin. Pathol. 1979;32:798–801.
- Jain U, Otley AR, Van Limbergen J, Stadnyk AW. The complement system in inflammatory bowel disease. Inflamm. Bowel Dis. 2014;20:1628–1637.
- Lipinski S, et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J. Cell Sci. 2009;122:3522–3530.
- Yung SC, Murphy PM. Antimicrobial chemokines. Front. Immunol. 2012;3:276.
- Pasolli E, et al. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell. 2019;176:649–662e620.
- Ralling G, Bodrug S, Linn T. Growth rate-dependent regulation of RNA polymerase synthesis in Escherichia coli. Mol. Gen. Genet. 1985;201:379–386.
- Sokol H, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA. 2008;105:16731–16736.
- Vítek L. Bile acid malabsorption in inflammatory bowel disease. Inflamm. Bowel Dis. 2015;21:476–483.
- Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J. Lipid Res. 2015;56:1085–1099.
- Walsham NE, Sherwood RA. Fecal calprotectin in inflammatory bowel disease. Clin. Exp. Gastroenterol. 2016;9:21–29.
- Truong DT, Tett A, Pasolli E, Huttenhower C, Segata N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 2017;27:626–638. doi: 10.1101/gr.216242.116.
- Ricklin D, Reis ES, Lambris JD. Complement in disease: a defence system turning offensive. Nat. Rev. Nephrol. 2016;12:383–401.
- Franzosa EA, et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl Acad. Sci. USA. 2014;111:E2329–E2338.
- Vogtmann E, et al. Comparison of collection methods for fecal samples in microbiome studies. Am. J. Epidemiol. 2017;185:115–123.
- Loftfield E, et al. Comparison of collection methods for fecal samples for discovery metabolomics in epidemiologic studies. Cancer Epidemiol. Biomarkers Prev. 2016;25:1483–1490.
- Voigt AY, et al. Temporal and technical variability of human gut metagenomes. Genome Biol. 2015;16:73.
- Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am. J. Gastroenterol. 2001;96:2921–2928.
- Daperno M, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest. Endosc. 2004;60:505–512.
- Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ. 1964;1:89–92.
- Schirmer M, et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol. 2018;3:337–346.
- Shishkin AA, et al. Simultaneous generation of many RNA-seq libraries in a single reaction. Nat. Methods. 2015;12:323–325.
- Zhu YY, Machleder EM, Chenchik A, Li R, Siebert PD. Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction. Biotechniques. 2001;30:892–897.
- Clem AL, Sims J, Telang S, Eaton JW, Chesney J. Virus detection and identification using random multiplex (RT)-PCR with 3′-locked random primers. Virol. J. 2007;4:65.
- Ajami NJ, Wong MC, Ross MC, Lloyd RE, Petrosino JF. Maximal viral information recovery from sequence data using VirMAP. Nat. Commun. 2018;9:3205.
- Kostic AD, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015;17:260–273.
- Kim S, Pevzner PA. MS-GF+ makes progress towards a universal database search tool for proteomics. Nat. Commun. 2014;5:5277.
- Thompson LR, et al. A communal catalogue reveals Earth’s multiscale microbial diversity. Nature. 2017;551:457–463.
- Caporaso JG, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621–1624.
- Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214.
- Human Microbiome Project Consortium A framework for human microbiome research. Nature. 2012;486:215–221.
- Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–2461.
- Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods. 2013;10:996–998.
- Pruesse E, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35:7188–7196.
- Landers CJ, et al. Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689–699.
- Targan SR, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease. Gastroenterology. 2005;128:2020–2028.
- Fisher S, et al. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol. 2011;12:R1.
- Gu H, et al. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat. Protocols. 2011;6:468–481.
- McIver LJ, et al. bioBakery: A meta’omic analysis environment. Bioinformatics. 2018;34:1235–1237.
- Truong DT, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods. 2015;12:902–903.
- Franzosa EA, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods. 2018;15:962–968.
- Huang K, et al. MetaRef: a pan-genomic database for comparative and community microbial genomics. Nucleic Acids Res. 2014;42:D617–D624.
- Suzek BE, Wang Y, Huang H, McGarvey PB, Wu CH. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics. 2015;31:926–932.
- Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2016.
- Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat. Methods. 2015;12:59–60.
- Oksanen, J. et al. vegan: Community Ecology Package. R package version 2.5-3. (2018).
- Pinheiro, J. et al. nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-108. (2013).
- Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140.
- McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288–4297.
- Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353–D361.
- Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
- The 1000 Genomes Project Consortium A global reference for human genetic variation. Nature. 2015;526:68–74.
- Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559–575.
- Jostins L, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.
- Liu JZ, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 2015;47:979–986.
- Hall AB, Tolonen AC, Xavier RJ. Human genetic variation and the gut microbiome in disease. Nat. Rev. Genet. 2017;18:690–699.
- Enattah NS, et al. Identification of a variant associated with adult-type hypolactasia. Nat. Genet. 2002;30:233–237.
- Sheather SJ, Jones MC. A reliable data-based bandwidth selection method for kernel density estimation. J. R. Stat. Soc. 1991;53:683–690.
- Kenward MG, Roger JH. An improved approximation to the precision of fixed effects from restricted maximum likelihood. Comput. Stat. Data Anal. 2009;53:2583–2595.
- Faith JJ, et al. The long-term stability of the human gut microbiota. Science. 2013;341:1237439.
- Kolde, R. Pheatmap: pretty heatmaps. R Package Version 1.0.10. (2012).
- Gibbons RD, Hedeker D, DuToit S. Advances in analysis of longitudinal data. Annu. Rev. Clin. Psychol. 2010;6:79–107.
- Minot S, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011;21:1616–1625.
- Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
- Gonzalez A, et al. Qiita: rapid, web-enabled microbiome meta-analysis. Nat. Methods. 2018;15:796–798.
- Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–210.
- Vizcaíno JA, et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2016;44:D447–D456.
- Suzek BE, Huang H, McGarvey P, Mazumder R, Wu CH. UniRef: comprehensive and non-redundant UniProt reference clusters. Bioinformatics. 2007;23:1282–1288.
- Bar-Joseph Z, Gifford DK, Jaakkola TS. Fast optimal leaf ordering for hierarchical clustering. Bioinformatics. 2001;17(Suppl. 1):S22–S29.
- Silverman, B. W. Density Estimation for Statistics and Data Analysis 48, eqn 43.31 (Chapman and Hall, 1986).
- Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–678.
Source: PubMed